BoneUP Live @ ASBMR 2026 - Part 4
Failed to add items
Add to basket failed.
Add to wishlist failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
BoneUP Live @ ASBMR 2026 - Part 4
-
Narrated by:
-
By:
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!
David Armstrong and Richie Abel recorded brand new interviews at ASBMR 2026 in Boston, Massachusetts. In this fourth episode the lads chatted to three more guests.
Dr Jude Bubbear (Consultant in Metabolic Bone Disease, Royal National Orthopaedic Hospital) describes real-world data from the UK early access programme for burosumab in X-linked hypophosphataemia. Ten patients over 65 had reductions in pain and stiffness and improvements in quality of life.
Guillaume Mabilleau (Associate Professor, Université d’Angers) explains how GLP-1 receptor agonists act on bone mainly through enzymatic collagen cross-linking. In animal models semaglutide also reduced grip strength even after adjusting for weight loss.
Nour El Houda Goucem (Professional Research Assistant, CU Anschutz) describes the genotyping, histology, DEXA and micro-CT work behind mouse studies of bone. Nour also explains how research experience is preparing her for medical school.
Join us for more interviews from the conference in the next part.